Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study
Ryo Toyozawa,
Fumihiro Shoji,
Takanori Yamashita,
Fumihiko Kinoshita,
Shinkichi Takamori,
Takatoshi Fujishita,
Kensaku Ito,
Koji Yamazaki,
Naoki Nakashima,
Tatsuro Okamoto
Affiliations
Ryo Toyozawa
Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Fumihiro Shoji
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
Takanori Yamashita
Medical Information Center, Kyushu University, Fukuoka, Japan
Fumihiko Kinoshita
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
Shinkichi Takamori
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
Takatoshi Fujishita
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
Kensaku Ito
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
Koji Yamazaki
Department of Thoracic Surgery, National Hospital Organisation Kyushu Medical Center, Fukuoka, Japan
Naoki Nakashima
Medical Information Center, Kyushu University, Fukuoka, Japan
Tatsuro Okamoto
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
